EHA 2019: EPO in treatment of autoimmune hemolytic anemia

Sigbjørn Berentsen | | Juni 18, 2019

Speaker: Sigbjørn Berentsen

In this MEDtalkSigbjørnBerentsenpresent data that advise EPO use to stimulate bone marrow compensatory response. The results from this international studyshows, that EPO is effective in about 70% of AIHA patients unresponsive to ongoing/previous treatments.